Peura L[au] - Search Results

Year	Number of Results
2009	1
2011	2
2012	1
2013	2
2014	3
2015	1
2016	1
2022	0

1

[Prodrug technology in the development of medicinal agents].

Peura L, Malmioja K, Rautio J. Peura L, et al. Duodecim. 2011;127(3):263-72. Duodecim. 2011. PMID: 21438349 Review. Finnish.

2

Brain pharmacokinetics of ganciclovir in rats with orthotopic BT4C glioma.

Gynther M, Kääriäinen TM, Hakkarainen JJ, Jalkanen AJ, Petsalo A, Lehtonen M, Peura L, Kurkipuro J, Samaranayake H, Ylä-Herttuala S, Rautio J, Forsberg MM. Gynther M, et al. Among authors: peura l. Drug Metab Dispos. 2015 Jan;43(1):140-6. doi: 10.1124/dmd.114.059840. Epub 2014 Oct 27. Drug Metab Dispos. 2015. PMID: 25349125

3

Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure.

Gynther M, Peura L, Vernerová M, Leppänen J, Kärkkäinen J, Lehtonen M, Rautio J, Huttunen KM. Gynther M, et al. Among authors: peura l. Neurochem Res. 2016 Oct;41(10):2797-2809. doi: 10.1007/s11064-016-1996-8. Epub 2016 Jul 14. Neurochem Res. 2016. PMID: 27412117

4

Sustained release of metformin via red blood cell accumulated sulfenamide prodrug.

Peura L, Huttunen KM. Peura L, et al. J Pharm Sci. 2014 Jul;103(7):2207-2210. doi: 10.1002/jps.24040. Epub 2014 Jun 2. J Pharm Sci. 2014. PMID: 24891115

5

Quantitative insight into the design of compounds recognized by the L-type amino acid transporter 1 (LAT1).

Ylikangas H, Malmioja K, Peura L, Gynther M, Nwachukwu EO, Leppänen J, Laine K, Rautio J, Lahtela-Kakkonen M, Huttunen KM, Poso A. Ylikangas H, et al. Among authors: peura l. ChemMedChem. 2014 Dec;9(12):2699-707. doi: 10.1002/cmdc.201402281. Epub 2014 Sep 9. ChemMedChem. 2014. PMID: 25205473

6

Design, synthesis and brain uptake of LAT1-targeted amino acid prodrugs of dopamine.

Peura L, Malmioja K, Huttunen K, Leppänen J, Hämäläinen M, Forsberg MM, Gynther M, Rautio J, Laine K. Peura L, et al. Pharm Res. 2013 Oct;30(10):2523-37. doi: 10.1007/s11095-012-0966-3. Pharm Res. 2013. PMID: 24137801

7

Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.

Gynther M, Ropponen J, Laine K, Leppänen J, Haapakoski P, Peura L, Järvinen T, Rautio J. Gynther M, et al. Among authors: peura l. J Med Chem. 2009 May 28;52(10):3348-53. doi: 10.1021/jm8015409. J Med Chem. 2009. PMID: 19402664

8

Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion.

Ylikangas H, Peura L, Malmioja K, Leppänen J, Laine K, Poso A, Lahtela-Kakkonen M, Rautio J. Ylikangas H, et al. Among authors: peura l. Eur J Pharm Sci. 2013 Feb 14;48(3):523-31. doi: 10.1016/j.ejps.2012.11.014. Epub 2012 Dec 8. Eur J Pharm Sci. 2013. PMID: 23228412

9

Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.

Peura L, Malmioja K, Laine K, Leppänen J, Gynther M, Isotalo A, Rautio J. Peura L, et al. Mol Pharm. 2011 Oct 3;8(5):1857-66. doi: 10.1021/mp2001878. Epub 2011 Aug 9. Mol Pharm. 2011. PMID: 21770378

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results